ReviewChildhood kidney diseases2024
Integrating predictive modeling and causal inference for advancing medical science.
Review in Childhood kidney diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- DeepDiff-SHAP: Interpretable deep learning for subgroup-specific causal hypothesis generation using conditional SHAP.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is revolutionizing healthcare by providing tools for disease prediction, diagnosis, and patient management. This review focuses on two key AI methodologies in healthcare: predictive modeling and causal inference. Predictive models excel in identifying patterns to forecast outcomes but are limited in explaining the underlying causes. In contrast, causal inference focuses on understanding cause-and-effect relationships, which makes effective medical interventions possible. Although randomized controlled trials (RCTs) are the gold standard for causal inference, they face limitations including cost and ethical concerns. As alternatives, emulated RCTs and advanced machine learning techniques have emerged for estimating causal effects, bridging the gap between prediction and causality. Additionally, Shapley values and Local Interpretable Model-Agnostic Explanations improve the interpretability of complex AI models, making them more actionable in clinical settings. Integrating prediction and causal inference holds great promise for advancing personalized medicine, enhancing patient outcomes, and optimizing healthcare delivery. However, careful application of AI tools is crucial to avoid misinterpretation and maximize their potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.